I am stage IIA and opted for adjuvant chemo with Xeloda 6 months. I'm halfway through. I got multiple oncologist opinions, and I think with the new data discussed in the CRC conference this past June, more people will recommend "a little Xeloda" for Stage IIA. A little meaning maybe just 3 months -- the side effect profile would be mild enough to justify its use.
Had I been higher stage or showed any "high risk features," I wouldn't even have debated chemo vs no chemo. I would probably been discussing what kind of chemo instead. We each make a choice. I didn't want to regret anything. My hands and feet are peeling and I can't use touchID to use my phone anymore, but I'm still fully on board with my decision.
Best of luck!
Stage IIA rectosigmoid CC (T3N0M0)
Dx 6/5/17 @age 41, mom to 5 & 2yo girls
Workup: c-scope, EUS, rectal MRI, CT C/A/P
AdenoCA 5.5cm, WHO Grade 2, 0/22 LN, no distant mets
CEA 1.9 (6/5/17), 0.8 (2/28/18)
No lymphovasc/perineural invasion, clear margins
MSI intact, OncotypeDx RS 7
Lap sig colectomy 6/23/17, no ileo/colostomy
Genetics counseling negative for mutations, 4 VUS
Xeloda monotherapy 8/13/17-1/22/18
PET/CT 3/21/18 NED